Annexin V Expression and Anti-Annexin V Antibodies in Type 1 Diabetes

Creative Commons License

BAKAR ATEŞ F., ÜNLÜTÜRK U., Baskal N., Nebioglu S.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, cilt.99, sa.3, ss.932-937, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 99 Sayı: 3
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1210/jc.2013-2592
  • Dergi Adı: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.932-937
  • Ankara Üniversitesi Adresli: Evet

Özet

Background: Annexin V (AnxV) has potent anticoagulant properties and regulatory functions for apoptosis and inflammation. Antibodies against annexin V (anti-AnxVs) may inhibit AnxV functions, leading to thrombosis during autoimmune diseases. Type 1 diabetes is an autoimmune disease and related with an ongoing autoimmune inflammation and thrombotic complications. There is no study evaluating anti-AnxVs/AnxV in a disease setting.